INSIGHTS ON DRUG DEVELOPMENT
-
Rapidly Assess Drug Response In 2D And 3D Breast Cancer Model Systems
For years, 2D cell cultures have been crucial in drug discovery. Explore how 3D cultures offer more biologically relevant models today that enhance cancer research and drug efficacy assessments.
-
The Next Generation Of Thermal Stability Testing For Biologic Drugs
Achieving precise measurements in a high-throughput setting can be challenging without disrupting workflows or deadlines. Learn about a new tool for rapid biotherapeutic thermal stability characterization.
-
Risk Management Processes For Cell And Gene Therapies
Delve into several considerations of risk and knowledge management in the cell and gene therapy environment, providing essential insights for effective product development.
-
Rapid Automated Selection Of Mammalian Cell Colonies
Discover how a new technology cultivates mammalian cells into clonal colonies and images them using fluorescent assays to isolate clonal cell populations based on surface protein expression.
-
Optimization And Scale-Up Of A Plasmid DNA Production Process9/30/2025
Optimizing pDNA production in E. coli requires strategic media selection and scale-up planning. Explore a study that identifies ideal conditions for high-yield manufacturing.
-
Accelerate FDA Approval With Fast Track Designation7/3/2025
Learn how Fast Track Designation streamlines the FDA review process and offers faster approval for serious diseases or life-threatening conditions.
-
Predicting Performance Of Lotions Through Rheological Characterization5/6/2026
Rheological testing shows how small formulation differences influence spreading, flow, and feel during use. With minimal sample volumes, these methods connect lab measurements to real‑world performance.
-
Your AKTA Oligosynt™ System : It's More Than A Machine2/9/2026
Discover how early choices in oligo synthesis workflows shape performance. Learn what to consider across design, reagents, and system optimization to build a process ready for smooth scale‑up.
-
Lightning-Link® Conjugation Kits: Consistent Performance On A Broad Scale9/26/2024
Learn about labeling technology offering a transformative solution through direct antibody labeling without the need for post-conjugation purification, thereby mitigating antibody loss and ensuring reproducible results.
DRUG DEVELOPMENT SOLUTIONS
-
Find what you need to move your Alzheimer’s research forward faster, with antibodies to 95% of core AD genes validated in imaging applications with human samples.
-
The Powder Rheology Accessory expands the DHR’s capabilities to powders, enabling the characterization of behaviors during storage, dispensing, processing, and end-use.
-
Discover how collaboration and reliability drive meaningful impact across the healthcare and life sciences industries by empowering innovation from lab to clinic.
-
MaxPeak™ Premier Columns utilize MaxPeak High Performance Surfaces that are designed to increase analyte recovery, sensitivity, and reproducibility by minimizing analyte/surface interactions that can lead to sample losses.
-
Waters MaxPeak Premier Columns and Solutions dramatically reduce NSA with MaxPeak High Performance Surfaces, innovative technologies designed to reduce analyte loss due to analyte/surface interactions.